Stanley Marks

Stanley M.
Marks is the founder of Oncology Hematology Associates, founded in 1978.
Dr. Marks is the founder of Cancer Treatment Services International, Inc., founded in 2006, and serves as Chairman.
Dr. Marks is also the founder of JDRF International.
Dr. Marks is currently Chairman & Chief Medical Officer at UPMC Cancer Institute.
Dr. Marks is currently Chairman at PredxBio, Inc. starting in 2023.
Dr. Marks is currently Director at CytoAgents, Inc. Dr. Marks is currently Chief-Hematology & Oncology Division at UPMC Shady Side Hospital.
Dr. Marks is currently Clinical Professor at the University of Pittsburgh School of Medicine.
Former positions include Director at OnCure Medical Corp., Director at American Cancer Society, Inc., Director at The Burger King Cancer Caring Center, Director at OnCure Holdings, Inc., President & Director at Allegheny County Medical Society, Member at Harvard University, Chief Medical Officer & Senior Vice President at South Broward Hospital District, President at The Leukemia & Lymphoma Society, Inc., and Member at Highmark West Virginia, Inc. Education includes an undergraduate degree from the University of Pittsburgh, conferred in 1969, and a doctorate from the University of Pittsburgh, conferred in 1973.